MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit The Times and Democrat11/22Follow Share to:By THE ROSEN LAW FIRM, P. A.NEW YORK , Nov. 22, 2025 /PRNewswire/ --See Full Page9